​

Mural Oncology Ownership | Who Owns Mural Oncology?

OverviewRevenueFinancialsChart

Mural Oncology Ownership Summary

Mural Oncology is owned by 16.22% institutional investors, 13.17% insiders, and 70.61% retail investors. Prosight management, lp is the largest institutional shareholder, holding 2.49% of MURA shares.

MURA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockMural Oncology16.22%13.17%70.61%
SectorHealthcare Stocks 279.42%10.64%-190.05%
IndustryBiotech Stocks 64.05%10.69%25.27%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Prosight management, lp422.74K2.49%$532.66K
Millennium management169.00K1.00%$212.94K
Commerce bank---
Nicollet investment management---
Solas capital management---
Two sigma advisers, lp---
Alpine global management---
Krensavage asset management---
Jane street group---
Whittier trust---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Prosight management, lp422.74K0.17%$532.66K
Millennium management169.00K0.00%$212.94K
Commerce bank---
Nicollet investment management---
Solas capital management---
Two sigma advisers, lp---
Alpine global management---
Krensavage asset management---
Jane street group---
Whittier trust---

Top Buyers

HolderShares% AssetsChange
Millennium management169.00K0.00%746.00
Versant capital management---1.00
Bell investment advisors---4.00
Cranbrook wealth management---4.00
Ronald blue trust---6.00

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.72M
Solas capital management---888.00K
Squarepoint ops---175.50K
Bridgeway capital management---115.87K
Shay capital---113.52K

Sold Out

HolderChange
Versant capital management-1.00
Bell investment advisors-4.00
Cranbrook wealth management-4.00
Ronald blue trust-6.00
Northwestern mutual wealth management-10.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20254-94.59%2,749,454-70.69%160.54%1-96.15%3-86.96%
Dec 31, 2024745.71%9,381,197-1.48%541.76%2618.18%23-11.54%
Sep 30, 202470-14.63%9,521,654-12.63%551.35%22-31.25%26-16.13%
Jun 30, 202482-14.58%10,897,815-9.88%641.24%326.67%31-34.04%
Mar 31, 202496-20.66%12,092,738-9.53%721.12%30-75.00%47-

Recent Insider Transactions

DateNameRoleActivityValue
Jul 22, 2025Keson-Brookes Maiken See RemarksSell$6.38K
Jul 18, 2025Keson-Brookes Maiken See RemarksSell$5.35K
Jul 07, 2025Loew Caroline Chief Executive OfficerSell$30.48K
Mar 04, 2025Keson-Brookes Maiken See RemarksSell$4.24K
Mar 05, 2025Keson-Brookes Maiken See RemarksSell$5.07K

Insider Transactions Trends

DateBuySell
2025 Q3-3
2025 Q2--
2025 Q1-4
2024 Q4-4
2024 Q312

MURA Ownership FAQ

Who Owns Mural Oncology?

Mural Oncology shareholders are primarily institutional investors at 16.22%, followed by 13.17% insiders and 70.61% retail investors. The average institutional ownership in Mural Oncology's industry, Biotech Stocks , is 64.05%, which Mural Oncology falls below.

Who owns the most shares of Mural Oncology?

Mural Oncology’s largest shareholders are Prosight management, lp (422.74K shares, 2.49%), Millennium management (169K shares, 1.00%), and Commerce bank (0 shares, 0%). Together, they hold 3.49% of Mural Oncology’s total shares outstanding.

Does Blackrock own Mural Oncology?

BlackRock is not among the top 10 institutional shareholders of Mural Oncology.

Who is Mural Oncology’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is Mural Oncology’s biggest shareholder by percentage of total assets invested, with 0.17% of its assets in 422.74K Mural Oncology shares, valued at 532.66K$.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools